abstract |
Compounds having the formula (I), wherein R 1 to R 11 , A and X 1 to X 3 are as described herein, and salts thereof are glucokinase (GLK) activities An agent, thereby being useful, for example, in the treatment of type 2 diabetes. Also described are methods of making the compounds of formula (I). |